Hear from Mitchel Sivilotti, President and CEO of OmniaBio, at Phacilitate as he discusses the groundbreaking integration of AI and robotics in OmniaBio’s operations. Mitch delves into OmniaBio’s strategic advancements and the role of our new commercial CDMO facility in Hamilton, Canada.
OmniaBio is excited to be pushing the boundaries of cell and gene therapy manufacturing with innovative technologies that enhance efficiency and provide substantial value to therapeutic developers.
Watch the video to explore the transformative efficiencies being realized through OmniaBio’s advanced manufacturing capabilities.